Correlation Between Enfusion and Marketwise

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enfusion and Marketwise at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and Marketwise into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and Marketwise, you can compare the effects of market volatilities on Enfusion and Marketwise and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of Marketwise. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and Marketwise.

Diversification Opportunities for Enfusion and Marketwise

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Enfusion and Marketwise is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and Marketwise in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marketwise and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with Marketwise. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marketwise has no effect on the direction of Enfusion i.e., Enfusion and Marketwise go up and down completely randomly.

Pair Corralation between Enfusion and Marketwise

Given the investment horizon of 90 days Enfusion is expected to generate 0.44 times more return on investment than Marketwise. However, Enfusion is 2.26 times less risky than Marketwise. It trades about 0.03 of its potential returns per unit of risk. Marketwise is currently generating about -0.04 per unit of risk. If you would invest  905.00  in Enfusion on August 25, 2024 and sell it today you would earn a total of  131.00  from holding Enfusion or generate 14.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Enfusion  vs.  Marketwise

 Performance 
       Timeline  
Enfusion 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Enfusion are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, Enfusion displayed solid returns over the last few months and may actually be approaching a breakup point.
Marketwise 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Marketwise has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Enfusion and Marketwise Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enfusion and Marketwise

The main advantage of trading using opposite Enfusion and Marketwise positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, Marketwise can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marketwise will offset losses from the drop in Marketwise's long position.
The idea behind Enfusion and Marketwise pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume